Previous studies have shown that the overexpression of PTGS2 is mediated by STAT3, and the inactivation of STAT3 is accompanied by the decreased expression of PTGS2 in hepatocellular carcinoma [46]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.